CIK 0001237831
- Large accelerated filer
GLOBUS MEDICAL INC
Sign in to watch- Ticker
- GMED
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043744954
- Phone
- +1 610-930-1800
- Business address
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,794,049
- in 3 filings, $425K under 10b5-1 plans
Net −$5,794,049. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-19 | Pfeil Keith W SVP, Chief Financial Officer | Sale | −834 | $78.25 | $65K | 0 |
| 2021-07-19 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −834 | 20,833 | ||
| 2021-07-02 | Scavilla Daniel T EVP, Chief Commercial Officer | Exercise or conversion | +50,000 | $25.52 | $1.3M | 50,000 |
| 2021-07-02 | Scavilla Daniel T EVP, Chief Commercial Officer | Exercise or conversion | +50,000 | $26.27 | $1.3M | 100,000 |
| 2021-07-02 | Scavilla Daniel T EVP, Chief Commercial Officer | Sale | −99,600 | $78.41 | $7.8M | 400 |
| 2021-07-02 | Scavilla Daniel T EVP, Chief Commercial Officer | Sale | −400 | $78.97 | $32K | 0 |
| 2021-07-02 | Scavilla Daniel T EVP, Chief Commercial Officer | Exercise or conversion · Stock Option (Right to buy Class A Common Stock) | −50,000 | 0 | ||
| 2021-07-02 | Scavilla Daniel T EVP, Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −50,000 | 30,000 | ||
| 2021-07-01 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion | +833 | $53.27 | $44K | 833 |
| 2021-07-01 | Pfeil Keith W SVP, Chief Financial Officer | Sale | −833 | $77.43 | $64K | 0 |
| 2021-07-01 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −833 | 25,000 | ||
| 2021-06-25 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion | +13,312 | $49.65 | $661K | 13,312 |
| 2021-06-25 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion | +14,167 | $53.27 | $755K | 14,167 |
| 2021-06-25 | Pfeil Keith W SVP, Chief Financial Officer | Sale | −27,479 | $75.04 | $2.1M | 0 |
| 2021-06-25 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −13,312 | 21,667 | ||
| 2021-06-25 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −14,167 | 25,833 | ||
| 2021-05-10 | TOBIN JAMES R Director | Exercise or conversion | +25,000 | $43.77 | $1.1M | 25,000 |
| 2021-05-10 | TOBIN JAMES R Director | Sale | −25,000 | $71.96 | $1.8M | 0 |
| 2021-05-10 | TOBIN JAMES R Director | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −25,000 | 0 | ||
| 2021-05-05 | Pfeil Keith W SVP, Chief Financial Officer | Exercise or conversion | +5,021 | $49.65 | $249K | 5,021 |
Page 14 of 25 · 498 trades